Target intelligence / Profile preview

Synovial joint surfaces and synovial fluid

Molecular classification
Other
01

Overview

Synovial joint surfaces and synovial fluid represent the specialized anatomical and physiological environment of diarthrodial joints, essential for low-friction movement and joint longevity (StatPearls, NBK532299). The synovial fluid is a dialysate of plasma containing high concentrations of hyaluronan and lubricin (proteoglycan 4), which together provide the viscoelastic properties necessary for lubrication and shock absorption (PubMed, 25135312). This compartment serves as the primary interface for nutrient and waste exchange for the avascular articular cartilage. In diseases such as osteoarthritis and rheumatoid arthritis, the biochemical integrity of the synovial fluid is compromised, characterized by decreased viscosity and increased pro-inflammatory cytokines like TNF-alpha and IL-1 beta (PubMed, 30033188). Consequently, this site is a major focus for local therapeutic interventions, including viscosupplements and intra-articular corticosteroids, which aim to restore the mechanical and biological homeostasis of the joint (PubMed, 28202310). Because this entry describes an anatomical region and biological fluid rather than a specific molecular target like a protein or enzyme, it is classified as an incorrect target designation in a strict pharmacological context.

Other names
Joint spaceSynovial compartmentArticular environmentSynoviumIntra-articular space
02

Mechanism of action

Viscosupplementation to restore the rheological properties of the fluid and local delivery of anti-inflammatory or analgesic agents to the articular environment.

03

Biological functions

Joint lubricationShock absorptionNutrient transport to articular cartilageWaste removalImmune surveillanceReduction of friction
04

Disease associations

OsteoarthritisRheumatoid arthritisGoutSeptic arthritisPseudogoutSynovitis
05

Safety considerations

Risk of iatrogenic septic arthritisPost-injection inflammatory flarePotential cartilage toxicity from repeated corticosteroid useSystemic absorption of locally administered drugsCrystal-induced synovitis
06

Interacting drugs

Hyaluronic acid

6 more in the full profile.

07

Biomarkers

Synovial fluid white blood cell countHyaluronic acid concentrationLubricin levelsC-reactive protein (CRP)Lactate dehydrogenase (LDH)Synovial fluid glucose levels

Beyond the preview

Go deeper on Synovial joint surfaces and synovial fluid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synovial joint surfaces and synovial fluid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call